1. Pink Sheet
  2. >>Geography
  3. >>Latin America

Brazilian Drug Price Increase Rates Hit Eight-Year Low

 
• By Francesca Bruce

CMED, which sets medicine prices in Brazil, has published the maximum price adjustment index for 2025.

Brazil's medicines regulator announces maximum price adjustments permitted in 2025. (Shutterstock)
Key Takeaways
  • CMED, which regulates medicine prices in Brazil, has published the annual maximum price adjustment index for medicines.
  • The average percentage increase of 3.83% permitted for 2025 is the lowest since 2018.

In 2025, companies operating in Brazil will see the lowest average maximum price adjustments legally permitted since 2018, according to the medicines regulator ANVISA.

The 2025 average maximum price increase for medicines permitted for 2025 will be 3.83%, which is below Brazil’s accumulated inflation rate of 5.06% over the past 12 months.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Latin America

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.